Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial
about
A Meta-Analysis of Randomized Clinical Trials Comparing Shorter (Less or Equal Than 6 Months) and Longer (More or Equal Than 12 Months) Dual Anti-Platelet Therapy Following Drug-Eluting Coronary StentsDevelopment and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.Causes of late mortality with dual antiplatelet therapy after coronary stents.Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelinesRisks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort StudyMortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study.Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy).Dual Antiplatelet Therapy of Clopidogrel and Aspirin in Secondary Prevention of Ischemic Stroke: Evidence and Indications.Dual Antiplatelet Therapy in Patients with Stable Ischemic Heart Disease.New directions for pharmacotherapy in the treatment of acute coronary syndrome.Antiplatelet Management for Coronary Heart Disease: Advances and Challenges.Is it time to take bare metal stents off the catheter laboratory shelf?Dual antiplatelet therapy after coronary stenting.Single or dual antiplatelet therapy after PCI.Dual Antiplatelet Therapy Beyond One Year in Patients After Stent Placement: A Review.Long-term dual antiplatelet therapy and concomitant optimal medical therapy following percutaneous coronary interventionLong-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.Real-world clopidogrel utilization in acute coronary syndromes: patients selection and outcomes in a single-center experience.2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.Duration of dual anti-platelet therapy following drug eluting stents: Less Is More?Assessing the optimal strategy for dual antiplatelet therapy.Efficacy and safety of prolonged dual antiplatelet therapy: a meta-analysis of 15 randomized trials enrolling 85 265 patients.Drug-eluting balloons with provisional bail-out or adjunctive stenting in de novo coronary artery lesions-a systematic review and meta-analysis.Novel Polymer-Free Everolimus-Eluting Stent Fabricated using Femtosecond Laser Improves Re-endothelialization and Anti-inflammation.Acute myocardial infarction occurring while on chronic clopidogrel therapy ('clopidogrel failure') is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis.2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
P2860
Q26784131-49CB8719-512E-40CA-9527-35F611277795Q33613297-E05FD3BB-1326-4A3A-917E-0467DE391AF8Q36369122-AE0E48E8-7D09-491D-92D8-163FE2179DDAQ36573521-77B3AF16-F3FF-426F-B51F-ABFB21B69749Q36682317-5AD1A91B-5E2F-4618-92AA-DA00DEA469E6Q36988677-A08F3A12-8194-4A8D-828A-000A42633256Q38379410-7D3351E3-FD6E-4358-B636-1BF571ED36D1Q38380436-AD789C02-8BF6-4CAD-A07C-3845E68CB02EQ38540055-A083AEE8-9424-4E80-8A3E-EABC9AC6A050Q38692636-92180D8A-A460-4D38-8B8B-3BA9D15ADED8Q38817144-13B77C2D-13E6-44CD-98F0-928EA9957987Q38824035-C4E5CD26-7624-4235-8601-FB89AA0278D2Q38860495-AF78E42F-5522-4CF3-8682-34FFF2E24A33Q38866836-B2F1B060-ED92-4ECB-9778-785362FEADD8Q38970275-26FBBB7A-8061-49CF-A404-303FB3654904Q39383567-DEEACA82-2710-4452-A257-D68AAD220146Q42333629-DF00195F-C3CE-414E-AFB5-4CABD80AC488Q44888352-0B226007-BCA4-48BE-9165-25174CEB9B86Q47580533-C9663DC8-3C1D-4698-8DDE-F02F6704929DQ50089557-9E6EC230-6E20-4579-8461-7EECEC25BC7DQ50868321-2ADA880D-B475-4221-8093-896C6A3C4019Q50950524-D420895E-964C-4395-A820-0386A2CB227DQ53581195-818196EA-F747-487E-A99D-D66DDA04D125Q55245991-7C71D4F3-7BBC-4919-8034-29C09EEF25A7Q55366209-9B9F96AF-6E21-4F8B-BC2F-45B638072C6DQ55473805-5CDD2306-B591-45D0-BEB8-B272B6B46C4DQ57621041-A0277728-0681-416B-9146-9E0CFB022240
P2860
Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Antiplatelet therapy duration ...... rapy randomized clinical trial
@ast
Antiplatelet therapy duration ...... rapy randomized clinical trial
@en
type
label
Antiplatelet therapy duration ...... rapy randomized clinical trial
@ast
Antiplatelet therapy duration ...... rapy randomized clinical trial
@en
prefLabel
Antiplatelet therapy duration ...... rapy randomized clinical trial
@ast
Antiplatelet therapy duration ...... rapy randomized clinical trial
@en
P2093
P2860
P356
P1476
Antiplatelet therapy duration ...... rapy randomized clinical trial
@en
P2093
Adrian Corneliu Iancu
Anthony H Gershlick
Daniel I Simon
David E Kandzari
David P Lee
Dean J Kereiakes
Donald E Cutlip
Dual Antiplatelet Therapy (DAPT) Study Investigators
Harald Darius
Ian T Meredith
P2860
P304
P356
10.1001/JAMA.2015.1671
P407
P577
2015-03-01T00:00:00Z